Table 1

Patient characteristics of patients in groups with full and incomplete compliance

Total cohortFull complianceIncomplete compliancep Value
Demographics
N (%)1732 (100)719 (41.5)1013 (58.5)
Age, mean (SD)61.3 (16.7)62.2 (16.4)60.6 (17.0)0.259
Gender (male), n (%)977 (56.4)411 (57.2)566 (55.9)0.594
Evaluated at the University Medical Centre, n (%)1258 (72.6)469 (65.2)789 (77.9)<0.001
Comorbidities, n (%)
COPD273 (15.8)142 (19.7)131 (12.9)<0.001
Heart failure222 (12.8)92 (12.8)130 (12.9)0.982
Liver disease78 (4.5)27 (3.8)51 (5.0)0.206
Renal disease296 (17.1)118 (16.4)178 (17.6)0.527
Nursing home resident111 (6.4)44 (6.1)67 (6.6)0.679
Immunocompromised (1)685 (39.5)228 (31.7)457 (45.1)<0.001
Malignancy (no metastases)204 (11.8)69 (9.6)13.5 (13.3)0.018
Malignancy (with metastases)211 (12.2)64 (8.9)147 (14.5)<0.001
DNR status (%) (5) 360 (20.8)145 (20.2)215 (21.2)0.558
Illness severity
Triage category, median (IQR) (2)4 (3–4)3 (3–4)3 (3–4)0.075
Total predisposition (P) and infection (I) score, median (IQR)4 (3–6)4 (3–6)4 (3–6)0.555
Total response (R) and organ failure (O) score, median (IQR)6 (2–8)6 (2–8)5 (2–8)0.130
Total PIRO score, median (IQR)9.7 (6–14)9.9 (6–14)9.6 (5–13)0.179
Acute-onset organ failure, n (%)353 (20.4)132 (18.4)221 (21.8)0.078
Number of acute failing organs, median (IQR)0 (0–0)0 (0–0)0 (0–0)
Admission to ICU, n (%) (4)178 (10.3)74 (10.3)104 (10.3)0.982
Vital signs at ED presentation
Systolic blood pressure, mean (SD) (236)132.6 (26.2)134.7 (26.4)131.1 (26.0)0.659
Heart rate, mean (SD) (43)108.4 (19.8)109.5 (19.5)107.7 (20.0)0.504
Respiratory rate, mean (SD) (515)24 (19–30)25.4 (7.7)24.4 (7.6)0.620
Oxygen saturation, mean (SD) (67)95.2 (4.9)94.8 (5.5)95.4 (4.4)0.053
Temperature (°C), mean (SD) (41)38.7 (1.9)38.9 (2.4)38.6 (1.6)0.724
Laboratory analysis at ED presentation
Lactate (mmol/L), median (IQR) (228)1.8 (1.3–2.5)1.7 (1.3–2.4)1.8 (1.4–2.7)0.004
Platelets (×109/L), median (IQR) (37)207 (151–276)207 (160–272)207 (146–279)0.362
INR median (IQR), (690)1.1 (1–1.5)1.1 (1.0–1.3)1.1 (1.0–1.6)0.001
Creatinine (µg/L), median (IQR) (14)87 (67–120)86 (67–117)88 (67–122)0.265
Urea (mmol/L), median (IQR) (15)7 (5.1–10.3)6.8 (5.0–9.9)7.1 (5.1–0.5)0.164
Bilirubin (µmol/L), median (IQR) (418)12 (8–18)12 (8–18)12 (8–19)0.742
Quality performance measures
Time to antibiotics (min), median (IQR) (34)100 (54–164)79 (47–121)124 (65–218)<0.001
Amount of intravenous fluids administered (L), median (IQR) (5)1 (0.5–1.5)1 (0.5–1.5)1 (0.5–1.5)
Appropriate antibiotics given, n (%) (42)1387 (80.1)719 (100)668 (65.9)<0.001
Lactate measured within 6 hours, n (%)1504 (86.8)719 (100)785 (77.5)<0.001
Blood cultures drawn before antibiotics administration, n (%)1639 (94.6)719 (100)920 (90.8)<0.001
Antibiotics administered within 3 hours, n (%) (34)1374 (79.3)719 (100)655 (64.7)<0.001
Mean arterial pressure ≥65 mm Hg within 6 hours, n (%) (13)1650 (95.3)719 (100)931 (91.9)<0.001
Sufficient* fluid administration circulatory organ failure, n (%) (5)1653 (95.4)719 (100)934 (92.2)<0.001
Necessary consultation with ICU attending, n (%) (55)1663 (96.0)719 (100)949 (93.7)<0.001
Correct ED diagnosis, n (%) (17)1448 (83.6)719 (100)729 (72.0)<0.001
Unanticipated transfer from ward to ICU, n (%) (74)74 (4.3)0 (0)74 (7.3)<0.001
In-hospital mortality, n (%)130 (7.5%)27 (3.8%)103 (10.2%<0.001
  • Patient characteristics were similar in ED patients in whom all quality performance measures were achieved (full compliance group) and in whom eight or less quality performance measures were achieved (incomplete compliance group).

  • *Administration of at least 1.5 L of fluids in the case of shock, in accordance with the SSC recommendations.8

  • Any amount of fluids was considered sufficient as long as an ED patient did not have signs of shock, that is, lactate >4 mmoL/L and/or systolic blood pressure <90 mm Hg or a decrease of the systolic blood pressure of >40 mm Hg compared with the baseline blood pressure of the ED patient.

  • COPD, chronic obstructive pulmonary disease; DNR, do not resuscitate order; ICU, intensive care unit; INR, international normalized ratio; PIRO, predisposition, infection, response, organ failure illness severity score; SSC, surviving sepsis campaign.